Common side effects include nausea, vomiting, and decreased appetite
Its important to know the specific risks of each medication to make informed choices
A specific set of criteria known as Rome III is widely used for diagnosing functional gastrointestinal disorders, including constipation and constipation-predominant irritable bowel syndrome (IBS-C) (Drossman 2006)
The article focuses on PIONEER 6, a phase 3a non-inferiority trial
Noom Med supports a range of evidence-based weight management medications, including but not limited to: GLP-1s: Wegovy , Zepbound , Ozempic , Mounjaro , liraglutide (generic), and more Other meds: Metformin, Contrave , topiramate Youll work closely with your Noom Med clinician throughout treatment
Long-term use safety Traditional pain meds: Not safe for years of continuous use Require breaks or rotation Accumulating damage to organs Peptides: Can use for months to years safely BPC-157 and TB-500 have decades of use data No cumulative toxicity Actually heal tissue rather than damage it Combining peptides with pain medications Can use together: Peptides for healing NSAIDs for acute breakthrough pain Reduce medication dose as peptides work Transition plan: Start peptides while on pain meds As pain improves, reduce medication slowly Goal: Minimal or no pain meds long-term See our peptide safety and risks guide